Metastasis-Directed Therapy Beneficial for Oligometastatic Prostate Cancer

MONDAY, Feb. 9, 2026 -- For patients with oligometastatic prostate cancer, metastasis-directed therapy (MDT) is beneficial for progression-free, radiological progression-free, and castration resistance-free survival, according to research published...